Heptadecan-9-yl 8-[(2-hydroxyethyl)({3-oxo-3-[2-(undecyloxy)ethoxy]propyl})amino]octanoate
Structure Info
- Chemspace ID
- CSSB20957408751 (In-Stock Building Blocks)
- IUPAC Name
- heptadecan-9-yl 8-[(2-hydroxyethyl)({3-oxo-3-[2-(undecyloxy)ethoxy]propyl})amino]octanoate
- Mol formula
- C43H85NO6
- Mol weight
- 712 Da
- Catalog Number(s)
- BBLS20957408751, BP-42501, bbls20957408751
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 12.83
- Heavy atoms count
- 50
- Rotatable bond count
- 43
- Number of rings
- 0
- Carbon bond saturation, Fsp3
- 0.953
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 1
![Chemical structure of Heptadecan-9-yl 8-[(2-hydroxyethyl)({3-oxo-3-[2-(undecyloxy)ethoxy]propyl})amino]octanoate (C43H85NO6) - CSSB20957408751](/st/structure/200/46d0897953e0c3f3cf50399cc49b69b9/CCCCCCCCCCCOCCOC%2528%253DO%2529CCN%2528CCO%2529CCCCCCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png "C43H85NO6")
- Zoom the structure
- CSSB20957408751
Items Overall 9 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 5 days | United States To: | 95 | 50 umol | 342.14 | |
| BB4LS US | 5 days | United States To: | 95 | 100 umol | 598.95 | |
| BB4LS US | 5 days | United States To: | 95 | 200 umol | 953.57 | |
| BB4LS US | 5 days | United States To: | 95 | 300 umol | 970.60 | |
| BB4LS US | 5 days | United States To: | 95 | 500 umol | 1,837.44 | |
| Broadpharm | 20 days | United States To: | 95 | 50 mg | 352.00 | |
| Broadpharm | 20 days | United States To: | 95 | 100 mg | 605.00 | |
| Broadpharm | 20 days | United States To: | 95 | 250 mg | 946.00 | |
| Broadpharm | 20 days | United States To: | 95 | 1 g | 1,760.00 | |
Description: BP Lipid 457 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of heptadecan-9-yl 8-[(2-hydroxyethyl)(3-oxo-3-{2-[2-(pentyloxy)ethoxy]ethoxy}propyl)amino]octanoate - CSSB20957408763](/st/structure/200/2e70c9b855c91930c2e80864df677c47/CCCCCCCCC%2528CCCCCCCC%2529OC%2528%253DO%2529CCCCCCCN%2528CCO%2529CCC%2528%253DO%2529OCCOCCOCCCCC.png)
![Chemical structure of heptadecan-9-yl 8-[(2-hydroxyethyl)[3-oxo-3-(2-{2-[2-(undecyloxy)ethoxy]ethoxy}ethoxy)propyl]amino]octanoate - CSSB14863683092](/st/structure/200/628740ee9373acd78db949587af113f3/CCCCCCCCCCCOCCOCCOCCOC%2528%253DO%2529CCN%2528CCO%2529CCCCCCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
![Chemical structure of heptadecan-9-yl 8-[(2-hydroxyethyl)({6-oxo-6-[2-(undecyloxy)ethoxy]hexyl})amino]octanoate - CSSB20957408765](/st/structure/200/33149e96b8288e373092bd2914238c2b/CCCCCCCCCCCOCCOC%2528%253DO%2529CCCCCN%2528CCO%2529CCCCCCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
![Chemical structure of heptadecan-9-yl 8-[(2-hydroxyethyl)[6-oxo-6-(2-{2-[2-(undecyloxy)ethoxy]ethoxy}ethoxy)hexyl]amino]octanoate - CSSB14813040481](/st/structure/200/a4ec9f54d45f1808a24fe86146f1fac9/CCCCCCCCCCCOCCOCCOCCOC%2528%253DO%2529CCCCCN%2528CCO%2529CCCCCCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
![Chemical structure of heptadecan-9-yl 3-(2-{2-[(2-hydroxyethyl)({3-oxo-3-[2-(undecyloxy)ethoxy]propyl})amino]ethoxy}ethoxy)propanoate - CSSB20957408769](/st/structure/200/ba2cfb8cf935e36f44776967c514167f/CCCCCCCCCCCOCCOC%2528%253DO%2529CCN%2528CCO%2529CCOCCOCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
![Chemical structure of 1-heptadecan-9-yl 19-(2-{2-[2-(undecyloxy)ethoxy]ethoxy}ethyl) 16-(2-hydroxyethyl)-4,7,10,13-tetraoxa-16-azanonadecanedioate - CSSB20957408768](/st/structure/200/9e799939bffd4a27580aef6bcfd635f3/CCCCCCCCCCCOCCOCCOCCOC%2528%253DO%2529CCN%2528CCO%2529CCOCCOCCOCCOCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
amino}octanoate - CSSB06741709365](/st/structure/200/9384ab0abd4914de1a426ae4dc64a6cd/CCCCCCCCCOC%2528%253DO%2529CCCCCCCN%2528CCO%2529CCCCCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
